An Axiron lawsuit has been filed over a heart attack death that plaintiffs contend was caused by testosterone replacement therapy. The complaint, filed on March 17 in the U.S. District Court for the Northern District of Illinois, Eastern Division, names Janice Ollenburger, individually and on behalf of Jerry Ollenburger, the... Read more »

Heart disease is one of the leading killers of both men and women in the United States, and experts across several medical fields have spent entire careers studying the direct or indirect causes of this destructive and chronic illness. In a recent study conducted by leading endocrinologists, researchers have uncovered... Read more »

On March 3, the U.S. Food and Drug Administration issued a warning on the testosterone heart attack risk for males using supplements to combat low levels of testosterone caused by aging. The FDA has required a labeling change to inform patients and the medical community of the possible increased risk... Read more »

For aging men, testosterone replacement therapy can help combat some of the physiological symptoms of decreasing testosterone levels – a condition known as “Low-T.” However, much like female hormone replacement therapy, Low-T treatments have come under increasing scrutiny for potential side effects and unexpected life-threatening ailments in patients receiving therapy... Read more »

Recent studies have provided conflicting and controversial results regarding testosterone drug risk to patients undergoing testosterone replacement therapy. However, a new report titled “Testosterone Therapy and Risk of Myocardial Infarction: A Pharmacoepidemiologic Study” published on January 13, found statistically significant results. Researchers Mahyar Etminan, Sean C. Skeldon, Sheldon Larry Goldenberg,... Read more »

U.S. District Judge Matthew Kennelly has prescribed a case management plan and process for preparing bellwether trials in testosterone injury lawsuits not involving AbbVie’s AndroGel product, but rather the various testosterone treatments marketed and sold by several other manufacturers. Judge Kennelly’s order further clarifies a specific area of distinction among... Read more »

The European Medicines Agency recently released a statement regarding testosterone drug risks for patients using drugs like Androgel, Axiron, AndroDerm and Testim. The November 21 statement noted that drugs should be used with caution, although researchers are still working to determine their link to health problems. The statement was released... Read more »

A new order permitting the direct filing of testosterone lawsuits into federal multidistrict litigation (MDL) has been issued by U.S. District Judge Matthew Kennelly, in the Northern District of Illinois. Judge Kennelly has been appointed to oversee the MDL ─ established in June 2014 ─ which includes lawsuits from plaintiffs... Read more »

Amid concerns over testosterone therapy side effects, an FDA panel has backed limitations on labeling for testosterone to exclude prescriptions for men who take the therapy only to counteract ordinary signs of aging rather than specific hormonal abnormalities. The panel also voted overwhelmingly to require clinical safety trials for some... Read more »

All testosterone therapy lawsuits filed in U.S. District Courts nationwide, alleging injuries because of Low T treatments, will now go before one judge in the Northern District of Illinois in centralized litigation known as “multidistrict litigation” or MDL. This move comes on the heels of June 6 order by a... Read more »